RUBRA MEDICAMENTS LTD. - 531099 - Related Party Disclosure For The Half Year Ended March 31, 2022
Related Party Disclosure for the half year ended March 31, 202225-05-2022
25-05-2022
RUBRA MEDICAMENTS LTD. - 531099 - Outcome Of Board Meeting
This is to inform you that the Board of Directors of the Company at its meeting held on Wednesday, May 25, 2022, inter alia, has considered and approved the following: A. Audited Standalone Financial Results for the year ended March 31, 2022 B. Asset liability statement, C. Cash Flow Statement, D. Audit Report thereon. E. Declaration for unqualified report You are requested to kindly take the same on your record.25-05-2022
RUBRA MEDICAMENTS LTD. - 531099 - Board Meeting Intimation for To Take On Record And Adopt The Standalone Audited Financial Results Of The Company For The Quarter And Year Ended March 31, 2022.
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2022 ,inter alia, to consider and approve The Standalone Audited Financial Results of The Company For The Quarter And Year Ended March 31, 2022.13-05-2022
RUBRA MEDICAMENTS LTD. - 531099 - Initial Disclosure To Be Made By An Entity Which Is Not A Large Corporate
Initial Disclosure to be made by an entity which is not a Large Corporate15-04-2022
RUBRA MEDICAMENTS LTD. - 531099 - Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Half Year Ended March 31, 2022
Compliance Certificate pursuant to Regulation 7(3) of SEBI (LODR) Regulations, 2015 for the half year ended March 31, 202215-04-2022
RUBRA MEDICAMENTS LTD. - 531099 - Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations, 2015 For The Half Year Ended March 31, 2022
The Certificate under Regulation 40(9) of the SEBI (LODR) Regulations, 2015 for the half year ended March 31, 2022 given by Practising Company Secretary11-04-2022
RUBRA MEDICAMENTS LTD. - 531099 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Rubra Medicaments Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here06-04-2022
RUBRA MEDICAMENTS LTD. - 531099 - Report Of Scrutinizer On Outcome Of Postal Ballot
Report of Scrutinizer on Outcome of Postal Ballot for:- I. Change in name of the Company to new name. II. Addition of new object in the main object of the company.06-04-2022
RUBRA MEDICAMENTS LTD. - 531099 - Outcome Of Postal Ballot
Approval of the shareholders by way of Postal Ballot for:- I. Change in name of the Company to new name. II. Addition of new object in the main object of the company.06-04-2022